Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Inventory Average (2016 - 2025)

Ligand Pharmaceuticals' Inventory Average history spans 15 years, with the latest figure at $10.5 million for Q4 2025.

  • For Q4 2025, Inventory Average changed N/A year-over-year to $10.5 million; the TTM value through Dec 2025 reached $10.5 million, changed N/A, while the annual FY2025 figure was $11.6 million, 38.98% down from the prior year.
  • Inventory Average for Q4 2025 was $10.5 million at Ligand Pharmaceuticals, down from $13.7 million in the prior quarter.
  • Across five years, Inventory Average topped out at $38.4 million in Q2 2021 and bottomed at $10.5 million in Q4 2025.
  • The 5-year median for Inventory Average is $23.1 million (2022), against an average of $22.8 million.
  • The largest annual shift saw Inventory Average soared 597.5% in 2021 before it tumbled 48.42% in 2023.
  • A 5-year view of Inventory Average shows it stood at $30.2 million in 2021, then plummeted by 40.95% to $17.8 million in 2022, then surged by 38.58% to $24.7 million in 2023, then decreased by 18.95% to $20.0 million in 2024, then crashed by 47.45% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Inventory Average are $10.5 million (Q4 2025), $13.7 million (Q3 2025), and $15.1 million (Q2 2025).